CD3⁺CD8⁺NKG2D⁺ T Lymphocytes Induce Apoptosis and Necroptosis in HLA‐Negative Cells via FasL–Fas Interaction

Abstract

An important problem in cellular immunology is to identify new populations of cytotoxic lymphocytes capable of killing tumor cells that have lost classical components of MHC-machinery and to understand mechanisms of the death of these cells. We have previously found that CD4 CD25 lymphocytes appear in the lymphokine-activated killer (LAK) cell culture, which carry Tag7 (PGRP-S) and FasL proteins on their surface and can kill Hsp70- and Fas-expressing HLA-negative cells. In this work, we have continued to study the mechanisms of killing of the HLA-negative tumor cells, focusing this time on the CD8 lymphocytes. We show that after a tumor antigen contact the IL-2 activated CD8 lymphocytes acquire ability to lyse tumor cells bearing this antigen. However, activation of the CD8 lymphocytes in the absence of antigen causes appearance of a cytotoxic population of CD8 NKG2D lymphocytes, which are able to lyse HLA-negative cancer cells that have lost the classic mechanism of antigen presentation. These cells recognize the noncanonical MicA antigen on the surface of HLA-negative K562 cells but kill them via the FasL-Fas interaction, as do cytotoxic T lymphocytes. FasL presented on the lymphocyte surface can trigger both apoptosis and necroptosis. Unlike in the case of TNFR1, another cell death receptor, no switching to alternative processes has been observed upon induction of Fas-dependent cell death. It may well be that the apoptotic and necroptotic signals are transduced separately in the latter case, with the ability of FasL lymphocytes to induce necroptosis allowing them to kill tumor cells that escape apoptosis. J. Cell. Biochem. 118: 3359-3366, 2017. © 2017 Wiley Periodicals, Inc.

Innate Immunity Protein Tag7 Induces 3 Distinct Populations of Cytotoxic Cells That Use Different Mechanisms to Exhibit Their Antitumor Activity on Human Leukocyte Antigen-Deficient Cancer Cells

“…We have recently shown that lymphocytes activated via IL-2 can induce both apoptosis and necroptosis via FasL-Fas interaction [30] . In our work, we have found that FasL from the lymphocytes surface can also trigger RIP1-dependent necroptosis in target cells.…”

Prognostic and therapeutic TILs of cervical cancer—Current advances and future perspectives

“…Indirectly, they can activate the Fas-FasL pathway to induce apoptosis of tumor cells. 43 , 44 Memory T cells can be classified into tissue-resident memory T (TRM) cells and central memory T (TCM) cells. 45 , 46 Under the stimulation of IL-15 and transforming growth factor β (TGF-β), CD8 + T cells can differentiate into TRM cells with high expression of CD69 and granzyme B.…”

Current translational potential and underlying molecular mechanisms of necroptosis

“…Type I 26–28 and type II 27,29 interferons have been published to induce increased expression of RIPK3, while constitutive IFNβ signaling was demonstrated to increase the intracellular level of MLKL 28 . CD8+T lymphocytes can trigger both apoptosis and necroptosis, which make these cells capable of killing tumor cells, even those that escaped apoptosis 30 . T cell-mediated necroptotic cytolysis also plays a role in activation induced cell death, and can be critical in the development of autoimmune reactions 31 .…”